Renal Cyst Management Guideline

Classification and Risk Assessment

The Bosniak classification system is used to predict malignancy risk in renal cysts, with Bosniak I and II cysts having approximately 0% risk, Bosniak IIF having 10% risk, Bosniak III having 50% risk, and Bosniak IV having 100% risk 1, 2
Simple renal cysts are characterized by well-defined margins, absence of internal echoes on ultrasound, and no contrast enhancement on CT or MRI, and changes in cyst characteristics warrant further investigation due to increased risk of malignancy 2

No intervention is required for asymptomatic simple renal cysts, and no routine follow-up imaging is necessary for confirmed Bosniak I and II cysts 1, 2
Active surveillance with repeat imaging in 6-12 months is recommended for Bosniak IIF cysts, with CT or MRI with and without contrast preferred for follow-up imaging 1
For Bosniak III/IV complex cystic renal masses, intervention is recommended when the anticipated oncologic benefits outweigh the risks, with nephron-sparing approaches prioritized, especially in patients with solitary kidney, bilateral tumors, known familial RCC, or preexisting chronic kidney disease 3, 4, 5

Laparoscopic cyst decortication may be considered for symptomatic cysts that fail aspiration and sclerotherapy, and partial nephrectomy should be prioritized for cT1a renal masses when intervention is indicated 3, 4, 5

Active surveillance is an option for initial management of patients with small (<2 cm) solid or Bosniak 3/4 complex cystic renal masses, with short-term cancer-specific survival rates exceeding 95% in well-selected patients 4

Core biopsies are not recommended for cystic renal masses due to low diagnostic yield unless areas with a solid pattern are present, and MRI has shown higher specificity than CT in characterizing renal lesions 1, 2
For confirmed benign renal masses, patients should undergo occasional clinical evaluation and laboratory testing for sequelae of treatment but do not require routine periodic imaging 3

Obtain high‑quality multiphase cross‑sectional imaging (contrast‑enhanced CT or MRI) when a renal cyst is identified to accurately assign a Bosniak category, which determines subsequent management. 6

Perform assessment of renal function (estimated GFR and proteinuria) in every patient with a renal mass to stage chronic kidney disease, as CKD stage influences surgical decision‑making for complex cystic lesions. 6

For Bosniak IIF cysts, adopt active surveillance with repeat imaging at 6–12 months; for Bosniak III and IV cysts, proceed to nephron‑sparing interventions when treatment is indicated. 7